A cost-effectiveness analysis of South Africa's COVID-19 vaccination programme.
Edoka I. et al, (2024), Vaccine
Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization.
Shattock AJ. et al, (2024), Lancet (London, England), 403, 2307 - 2316
Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) meeting, virtual gathering, 26 February-1 March 2024.
Lambach P. et al, (2024), Vaccine, 42, 3379 - 3383
Strengthening health policy modelling in Africa.
Thumbi SM. et al, (2024), The Lancet. Global health, 12, e555 - e556
The Full Value of Vaccine Assessments Concept-Current Opportunities and Recommendations.
White RG. et al, (2024), Vaccines, 12
Modelling the Cost-Effectiveness of Hepatitis A in South Africa.
Patterson J. et al, (2024), Vaccines, 12
Mobilizing resources with an investment case to mitigate cross-border malaria transmission and achieve malaria elimination in South Africa.
Kollipara A. et al, (2023), Global health action, 16
Differential in-hospital mortality and intensive care treatment over time: Informing hospital pathways for modelling COVID-19 in South Africa.
Jamieson L. et al, (2023), PLOS global public health, 3
The National COVID-19 Epi Model (NCEM): Estimating cases, admissions and deaths for the first wave of COVID-19 in South Africa.
Silal SP. et al, (2023), PLOS global public health, 3
The role of modelling and analytics in South African COVID-19 planning and budgeting.
Meyer-Rath G. et al, (2023), PLOS global public health, 3
Seasonal targeting of the RTS,S/AS01 malaria vaccine: a complementary tool but sustained funding is required.
Silal SP., (2022), The Lancet. Global health, 10, e1693 - e1694
COVID-19 response in South African communities: Screening, testing, tracing and movement modelling.
Modisenyane M. et al, (2022), South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 112, 366 - 370
Leveraging epidemiology as a decision support tool during the COVID-19 epidemic in South Africa
Silal SP. et al, (2022), SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 112, 361 - 365
A retrospective study assessing the clinical outcomes and costs of acute hepatitis A in Cape Town, South Africa.
Patterson J. et al, (2022), BMC infectious diseases, 22
Assessing the effectiveness of malaria interventions at the regional level in Ghana using a mathematical modelling application.
Awine T. and Silal SP., (2022), PLOS global public health, 2
Recommended reporting items for epidemic forecasting and prediction research: The EPIFORGE 2020 guidelines.
Pollett S. et al, (2021), PLoS medicine, 18
Investment case for malaria elimination in South Africa: a financing model for resource mobilization to accelerate regional malaria elimination.
Njau J. et al, (2021), Malaria journal, 20
Operational research: A multidisciplinary approach for the management of infectious disease in a global context.
Silal SP. and Modelling and Simulation Hub, Africa (MASHA) None., (2021), European journal of operational research, 291, 929 - 934
The Role of Remdesivir in South Africa: Preventing COVID-19 Deaths Through Increasing Intensive Care Unit Capacity.
Nichols BE. et al, (2021), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 72, 1642 - 1644
Cost-effectiveness of Remdesivir and Dexamethasone for COVID-19 Treatment in South Africa
Jo Y. et al, (2021), Open Forum Infectious Diseases, 8